HC Wainwright Trims Aclaris Therapeutics (NASDAQ:ACRS) Target Price to $9.00
Aclaris Therapeutics (NASDAQ:ACRS – Free Report) had its target price decreased by HC Wainwright from $43.00 to $9.00 in a research report sent to investors on Tuesday, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for Aclaris Therapeutics’ Q4 2023 earnings at ($0.50) EPS, […]
More Stories
Veritex (NASDAQ:VBTX) Stock Passes Below 200 Day Moving Average – Here’s Why
Veritex Holdings, Inc. (NASDAQ:VBTX – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday ....
Proton Motor Power Systems (LON:PPS) Stock Passes Below Two Hundred Day Moving Average – What’s Next?
Proton Motor Power Systems Plc (LON:PPS – Get Free Report)’s stock price passed below its 200-day moving average during trading...
Castings (LON:CGS) Shares Cross Below 200-Day Moving Average – What’s Next?
Castings P.L.C. (LON:CGS – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday ....
iShares MSCI Poland UCITS ETF USD (Acc) (LON:SPOL) Shares Cross Below Two Hundred Day Moving Average – Here’s What Happened
iShares MSCI Poland UCITS ETF USD (Acc) (LON:SPOL – Get Free Report)’s share price crossed below its two hundred day...
Analysts Set Harmonic Inc. (NASDAQ:HLIT) Target Price at $15.25
Harmonic Inc. (NASDAQ:HLIT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six ratings...
Vornado Realty Trust (NYSE:VNO) Receives Consensus Recommendation of “Hold” from Analysts
Vornado Realty Trust (NYSE:VNO – Get Free Report) has been given an average recommendation of “Hold” by the eleven ratings...